This is a $36,549,202.01 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the La Jolla Institute for Immunology, a non-profit research institute, for the Immune Epitope and Analysis Program. The contract has no set-aside designation and is set to run until December 14, 2025. As the prime contractor, the La Jolla Institute for Immunology is responsible for the overall program, which involves conducting research and providing services related to...
This is a definitive federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to the La Jolla Institute for Immunology, a non-profit research institute. The contract, valued at $5,624,672.00, is for the identification and characterization of T cell epitopes from bacterial pathogens causing pneumonia. This research aims to advance the understanding of immune responses to these bacterial...
This definitive federal contract was awarded by the Department of Health and Human Services' National Institute of Allergy and Infectious Diseases to the La Jolla Institute for Immunology, a non-profit research organization, to conduct large-scale T cell epitope discovery research. The contract has a potential value of $4,499,760.00 and is not set aside for any specific business type. The contract involves multiple subcontractors to assist with the research, including the Universidad Peruana...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the La Jolla Institute for Immunology, a non-profit research institute. The $5,982,815.17 definitive contract is for biomedical research services, with a period of performance from September 30, 2009 to September 29, 2014. The contract did not have a set-aside designation. The La Jolla Institute for Immunology, which conducts...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the La Jolla Institute for Immunology (LJII), a non-profit research institute. The contract, valued at $52,963,056.00, is for the "IMMUNE EPITOPE DATABASE AND ANALYSIS PROGRAM" and does not have a set-aside designation. The contract is a definitive contract with a cost-no-fee pricing type, with a period of performance ending on...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $5,624,889.00 definitive contract to the La Jolla Institute For Immunology, a non-profit research institute. The contract is for the identification and validation of epitopes conserved in viral pathogen families with pandemic potential. This is a cost-no-fee contract with a period of performance through September 29, 2025. The contract has no set-aside designation. The La Jolla Institute For...
This is a federal contract award (HHSN272200700048C) from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the La Jolla Institute for Immunology, a non-profit research institute. The $6,415,863 definitive contract is for biomedical research services, with a period of performance from September 2007 to December 2014. The contract does not have a set-aside designation. The La Jolla Institute for Immunology specializes in...
This is a federal contract award (HHSN272200900044C) to the La Jolla Institute for Immunology, a non-profit research institute, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract is for biomedical research services, has a ceiling value of $6,282,425.17, and was awarded on September 30, 2009 with a final completion date of September 29, 2014. The contract is a definitive contract with a cost-no-fee pricing...
This federal contract award from the Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, is for $7,346,666.00 to the La Jolla Institute for Immunology (LJI), a non-profit research institute, to conduct large-scale T cell epitope discovery. The contract has no set-aside designation and is a definitive contract with a cost-no-fee pricing type, with a completion date of September 29, 2024. LJI will collaborate with...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a $4,188,056.00 definitive cost-type contract to the Scripps Research Institute, a renowned nonprofit biomedical research organization, for a Large Scale Antibody and T Cell Epitope Discovery Program. This contract, which did not utilize any set-aside designations, is focused on advancing the development of novel vaccine candidates and therapeutics for infectious diseases. Scripps, which often serves as both a prime...
This is a $4,495,633 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the La Jolla Institute for Immunology, a non-profit research institute, for "LARGE SCALE T CELL EPITOPE DISCOVERY". The contract has no set-aside designation.
The contract involves T cell and B cell immunology research, including epitope identification, vaccine development, and studies on the immune mechanisms underlying infectious diseases, allergies, autoimmune disorders, and cancer. The La Jolla Institute for Immunology is the prime contractor, and it has subcontracted with the University of Oklahoma and University of Minnesota to provide specialized research services such as MHC II purification, mass spectrometry analysis, and supplying Bordetella pertussis cell lysates. This contract supports NIAID's broader mission of conducting and funding research to better understand, prevent, diagnose, and treat infectious, immunologic, and allergic diseases.